Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25

In this real-world cohort, both metastatic site and burden strongly influenced response and survival of avelumab. Bone metastases were independently associated with poor prognosis, while nodal-only disease identified a favorable subgroup. These findings support risk-based treatment stratification in the maintenance setting.

Authors

Institutions

Publication Details

Journal
Cancer Immunology Immunotherapy
Published
2026-02-14
DOI
https://doi.org/10.1007/s00262-025-04270-2
Primary Topic
Bone health and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25

S. Puglisi, Martina Catalano, Alessandro Rametta, Irene De Gennaro Aquino et al.
Cancer Immunology Immunotherapy
Bone health and treatments
article

Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25

S. Puglisi, Martina Catalano, Alessandro Rametta, Irene De Gennaro Aquino, Marinella Micol Mela, Giandomenico Roviello, Valentina Orlando, Sara Elena Rebuzzi, M. Maruzzo, Elisa Erbetta, G. Fornarini, Brigida Anna Maiorano, Elisabetta Gambale, Alessia Mennitto, Mariella Sorarù, C. Messina, Mimma Rizzo, Laura Doni, Luca Galli, Cecilia Nasso, Ismaela Anna Vascotto, Virginia Rossi, Alessia Salfi, Linda Cerbone, Davide Bimbatti, Chiara Mercinelli, Federico Scolari, Patrizia Giannatempo, Marco Messina
article en

Abstract

In this real-world cohort, both metastatic site and burden strongly influenced response and survival of avelumab. Bone metastases were independently associated with poor prognosis, while nodal-only disease identified a favorable subgroup. These findings support risk-based treatment stratification in the maintenance setting.

Cancer Immunology ImmunotherapyVol. 75(3)
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT), University of Udine (IT), University of Padua (IT), Vita-Salute San Raffaele University (IT), Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT), Ospedale Maggiore (IT), Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari (IT), Fondazione Ricerca Molinette (IT), Istituto Oncologico Veneto (IT), Azienda Ospedaliero-Universitaria Careggi (IT), Azienda Ospedaliero Universitaria Maggiore della Carita (IT), National Cancer Institute (MY), Azienda di Rilievo Nazionale ed Alta Specializzazione (IT), Ospedale Policlinico San Martino (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Ospedale di Prato Santo Stefano (IT), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), Ospedale Santa Corona (IT), Azienda Ospedaliera Universitaria Pisana (IT), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT), University of Florence (IT)
No poverty
Openalex Percentile: Top 55%
Bone health and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.